Hypercoagulable States in Cardiovascular Disease

DOI Web Site 1 Citations

Mark Y. Chan

From Duke Clinical Research Institute (M.Y.C., R.C.B.), Durham, NC; National University Hospital (M.Y.C.), Singapore, Singapore; Institute of Cardiology (F.A.), Catholic University, Rome, Italy; and Divisions of Cardiology and Hematology (R.C.B.), Duke University School of Medicine, Durham, NC.
Felicita Andreotti

From Duke Clinical Research Institute (M.Y.C., R.C.B.), Durham, NC; National University Hospital (M.Y.C.), Singapore, Singapore; Institute of Cardiology (F.A.), Catholic University, Rome, Italy; and Divisions of Cardiology and Hematology (R.C.B.), Duke University School of Medicine, Durham, NC.
Richard C. Becker

From Duke Clinical Research Institute (M.Y.C., R.C.B.), Durham, NC; National University Hospital (M.Y.C.), Singapore, Singapore; Institute of Cardiology (F.A.), Catholic University, Rome, Italy; and Divisions of Cardiology and Hematology (R.C.B.), Duke University School of Medicine, Durham, NC.

Journal

Circulation

Circulation 118 (22), 2286-2297, 2008-11-25

Ovid Technologies (Wolters Kluwer Health)

Back to top